Lupin Limited has informed the Exchange regarding a press release dated May 29, 2026, titled "Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets".
Lupin Limited has informed the Exchange regarding a press release dated May 29, 2026, titled "Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets".